Freenome
Decision/Risk AnalysisWebsite
Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. The company's platform uses a proprietary algorithm method that aims to reinvent disease m...
Valuation
$0
Share Price
N/A
Total Raised
$1.4B
Last Round
PIPE
Dec 2025
Latest Funding Round
PIPE
Dec 5, 2025
$240M
raised
Investors
+50 other investors